The global Insulin-like Growth Factors (IGFs) Market is entering a period of steady expansion, supported by rising demand for regenerative and growth-promoting therapies, increasing bone and tissue injuries, and broader research into cellular proliferation. Valued at US$ 274.4 Mn in 2023, the market is projected to advance at a CAGR of 5.8% from 2024 to 2034, reaching US$ 511.4 Mn by 2034.👉 Get...